173 related articles for article (PubMed ID: 27599683)
1. [Definition of accurate planning target volume margins for esophageal cancer radiotherapy].
Lesueur P; Servagi-Vernat S
Cancer Radiother; 2016 Oct; 20(6-7):651-6. PubMed ID: 27599683
[TBL] [Abstract][Full Text] [Related]
2. [Clinical to planning target volume margins in prostate cancer radiotherapy].
Ramiandrisoa F; Duvergé L; Castelli J; Nguyen TD; Servagi-Vernat S; de Crevoisier R
Cancer Radiother; 2016 Oct; 20(6-7):629-39. PubMed ID: 27614515
[TBL] [Abstract][Full Text] [Related]
3. [Choice of optimal margins in prostate conformal radiotherapy].
Khalifa J; Commandeur F; Bachaud JM; de Crevoisier R
Cancer Radiother; 2013 Oct; 17(5-6):461-9. PubMed ID: 23973458
[TBL] [Abstract][Full Text] [Related]
4. [Bladder cancer radiotherapy margins].
Régnier É; Nguyen TD; Beckendorf V; Lagrange JL
Cancer Radiother; 2013 Oct; 17(5-6):470-6. PubMed ID: 23969246
[TBL] [Abstract][Full Text] [Related]
5. [Margin determination from clinical to planning target volume for lung cancer treated with conformal or intensity-modulated irradiation].
Berthelot K; Thureau S; Giraud P
Cancer Radiother; 2016 Oct; 20(6-7):616-21. PubMed ID: 27614506
[TBL] [Abstract][Full Text] [Related]
6. [Image-guided radiotherapy for gynaecological cancer].
Lucia F; Schick U; Pradier O; Espenel S; de Crevoisier R; Chargari C
Cancer Radiother; 2018 Oct; 22(6-7):608-616. PubMed ID: 30126771
[TBL] [Abstract][Full Text] [Related]
7. [Clinical target volume delineation for radiotherapy of the esophagus].
Lazarescu I; Thureau S; Nkhali L; Pradier O; Dubray B
Cancer Radiother; 2013 Oct; 17(5-6):453-60. PubMed ID: 24011793
[TBL] [Abstract][Full Text] [Related]
8. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.
Shih HA; Jiang SB; Aljarrah KM; Doppke KP; Choi NC
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):613-22. PubMed ID: 15380599
[TBL] [Abstract][Full Text] [Related]
9. Esophageal motion during radiotherapy: quantification and margin implications.
Cohen RJ; Paskalev K; Litwin S; Price RA; Feigenberg SJ; Konski AA
Dis Esophagus; 2010 Aug; 23(6):473-9. PubMed ID: 20095993
[TBL] [Abstract][Full Text] [Related]
10. [Target volume margins for lung cancer: internal target volume/clinical target volume].
Jouin A; Pourel N
Cancer Radiother; 2013 Oct; 17(5-6):428-33. PubMed ID: 23988437
[TBL] [Abstract][Full Text] [Related]
11. Comparison of margins, integral dose and interfraction target coverage with image-guided radiotherapy compared with non-image-guided radiotherapy for bladder cancer.
Foroudi F; Pham D; Bressel M; Hardcastle N; Gill S; Kron T
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):497-505. PubMed ID: 24726459
[TBL] [Abstract][Full Text] [Related]
12. [Clinical to target volume margins determination in radiotherapy for anal cancers].
Libois V; Mahé MA; Rio E; Maingon P
Cancer Radiother; 2016 Oct; 20(6-7):645-50. PubMed ID: 27614499
[TBL] [Abstract][Full Text] [Related]
13. Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy.
Yamashita H; Haga A; Hayakawa Y; Okuma K; Yoda K; Okano Y; Tanaka K; Imae T; Ohtomo K; Nakagawa K
Acta Oncol; 2010 May; 49(4):485-90. PubMed ID: 20230211
[TBL] [Abstract][Full Text] [Related]
14. Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer.
Han C; Schiffner DC; Schultheiss TE; Chen YJ; Liu A; Wong JY
Radiother Oncol; 2012 Feb; 102(2):309-14. PubMed ID: 21872956
[TBL] [Abstract][Full Text] [Related]
15. [Are extensive fields useful for radiotherapy of esophageal cancer?].
Peyraga G; Capitain O; Rousseau D; Rio E; Septans AL; Baton O; Marquis A; Trémolières P; Gustin P; Ménager É; Branger F; Bressolette M; Deutsch É; Paumier A
Cancer Radiother; 2015 Aug; 19(5):313-21. PubMed ID: 26232314
[TBL] [Abstract][Full Text] [Related]
16. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
Button MR; Morgan CA; Croydon ES; Roberts SA; Crosby TD
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):818-23. PubMed ID: 18718726
[TBL] [Abstract][Full Text] [Related]
17. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
[TBL] [Abstract][Full Text] [Related]
18. Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use?
Whitfield GA; Jackson A; Moore C; Price P
Br J Radiol; 2008 Dec; 81(972):921-34. PubMed ID: 18794193
[TBL] [Abstract][Full Text] [Related]
19. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
20. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters.
Panakis N; McNair HA; Christian JA; Mendes R; Symonds-Tayler JR; Knowles C; Evans PM; Bedford J; Brada M
Radiother Oncol; 2008 Apr; 87(1):65-73. PubMed ID: 18267345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
